This AASLD 2018 Hepatitis B Guidance is intended to complement the AASLD 2016
Practice Guidelines for Treatment of Chronic Hepatitis B (1) and update the previous …

Hepatitis B reactivation associated with immune-suppressive and biological therapies is
emerging to be an important cause of morbidity and mortality in patients with current or prior …

Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

Hepatitis B virus (HBV) infection causes chronic hepatitis and has long term complications.
Individuals ever infected with HBV are at risk of viral reactivation under certain …

Infectious diseases are important causes of morbidity and mortality in patients with cancer.
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prevention and …

These guidelines have been written to assist physicians and other health care providers in
the recognition, diagnosis, and management of patients chronically infected with the …

Diseases (AASLD) also presented and continued to revise their clinical practice guidelines,
and the latest updates were in 2015, 2017, and 2018. However, since the medical …

Reactivation of hepatitis B refers to the abrupt increase in hepatitis B virus (HBV) replication
in a patient with inactive or resolved hepatitis B. Reactivation can occur spontaneously, but …

Purpose Reactivation of hepatitis B virus (HBV) infection is a well-recognized complication
in cancer patients with chronic HBV (hepatitis B surface antigen [HBsAg] positive) …

Importance Hepatitis B virus (HBV) reactivation is a serious complication for patients with
lymphoma treated with rituximab-containing chemotherapies, despite lamivudine …